REUTERS research report on MCLN. Interesting read. Report: http://biomedreports.com/research/doc_view/119-medclean-otcmcln-from-reuters.raw?tmpl=component CAPI is a competitor that used to trade at $.85 recently and much much higher years ago: http://biomedreports.com/research/doc_view/120-caprius-otccapi-from-reuters.raw?tmpl=component